• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二棕榈酰磷脂酰甘油在暴露于苯并[a]芘的肺表面活性剂中的作用。

The role of DPPG in lung surfactant exposed to benzo[a]pyrene.

机构信息

Department of Physical Chemistry and Electrochemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387, Krakow, Poland.

出版信息

Environ Sci Process Impacts. 2019 Mar 20;21(3):438-445. doi: 10.1039/c8em00497h.

DOI:10.1039/c8em00497h
PMID:30729964
Abstract

Lung surfactant (LS) occurs at the air-water interface in the alveoli. Its main function is to reduce the work needed to expand the alveoli during inhalation and prevent the alveolar collapse during exhalation. Disturbance of this complex interfacial system by the uptake of pollutant molecules can lead to changes in fluidity, permeability, phase separation and domain formation, which in turn can lead to serious impairment in lung function. Knowledge of the LS-pollutant interaction is essential for understanding the mechanism of this process. In this study, we investigate the interaction of LS models with benzo[a]pyrene (BaP). Dipalmitoylphosphatidylcholine (DPPC), dipalmitoylphosphatidylglycerol (DPPG) sodium salt, and their 4 : 1 mixture are used as LS models. Surface pressure-area isotherms and molecular dynamics simulations are employed to study the properties of LS monolayers. It was found that the addition of BaP has a destabilizing effect on the mixed DPPC/DPPG monolayer, manifested by the decrease in surface pressure. Compression of a monolayer during a respiratory cycle may expel BaP to the bulk solution. It was demonstrated that DPPG is an active component that prevents the BaP molecule from entering the water subphase; as a minor component of LS it can effectively reduce this process. In addition, the presence of BaP in LS models induces the reduction of monolayer hydration in the hydrophilic region and the increase in chain ordering in the hydrophobic region. The observed changes in monolayer fluidity and phase behavior can be a source of various lung function disorders.

摘要

肺表面活性剂 (LS) 存在于肺泡的气-液界面。其主要功能是降低吸气时扩张肺泡所需的功,并防止呼气时肺泡塌陷。污染物分子的摄取对这个复杂的界面系统的干扰,可能导致流动性、渗透性、相分离和域形成的变化,进而导致严重的肺功能障碍。了解 LS-污染物的相互作用对于理解这个过程的机制是至关重要的。在这项研究中,我们研究了 LS 模型与苯并[a]芘 (BaP) 的相互作用。二棕榈酰磷脂酰胆碱 (DPPC)、二棕榈酰磷脂酰甘油 (DPPG) 钠盐及其 4:1 的混合物被用作 LS 模型。表面压力-面积等温线和分子动力学模拟被用来研究 LS 单层的性质。结果表明,BaP 的加入对 DPPC/DPPG 混合单层有去稳定化作用,表现为表面压力的降低。呼吸循环中单层的压缩可能会将 BaP 挤出到体相溶液中。结果表明,DPPG 是一种活性成分,可阻止 BaP 分子进入水亚相;作为 LS 的次要成分,它可以有效地减少这个过程。此外,BaP 在 LS 模型中的存在诱导亲水区域单层水合作用的减少和疏水区域链序的增加。所观察到的单层流动性和相行为的变化可能是各种肺功能障碍的来源。

相似文献

1
The role of DPPG in lung surfactant exposed to benzo[a]pyrene.二棕榈酰磷脂酰甘油在暴露于苯并[a]芘的肺表面活性剂中的作用。
Environ Sci Process Impacts. 2019 Mar 20;21(3):438-445. doi: 10.1039/c8em00497h.
2
Modeling Lung Surfactant Interactions with Benzo[a]pyrene.苯并[a]芘与肺表面活性剂相互作用的建模。
Chemistry. 2017 Apr 19;23(22):5307-5316. doi: 10.1002/chem.201605945. Epub 2017 Mar 30.
3
Interactions of benzo[a]pyrene and diesel exhaust particulate matter with the lung surfactant system.苯并[a]芘与柴油机尾气颗粒物与肺表面活性物质系统的相互作用。
Ann Occup Hyg. 2011 Apr;55(3):329-38. doi: 10.1093/annhyg/mer007.
4
Investigation of Drug for Pulmonary Administration-Model Pulmonary Surfactant Monolayer Interactions Using Langmuir-Blodgett Monolayer and Molecular Dynamics Simulation: A Case Study of Ketoprofen.肺部给药药物研究-使用 Langmuir-Blodgett 单层膜和分子动力学模拟研究模型肺表面活性剂单层相互作用:以酮洛芬为例。
Langmuir. 2019 Oct 15;35(41):13452-13460. doi: 10.1021/acs.langmuir.9b02412. Epub 2019 Oct 3.
5
Pulmonary surfactant protein SP-A with phospholipids in spread monolayers at the air-water interface.肺表面活性物质蛋白SP-A与磷脂在气-水界面形成铺展单分子层。
Biochemistry. 1995 Aug 15;34(32):10279-89. doi: 10.1021/bi00032a023.
6
Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: I. Monolayers of pulmonary surfactant protein SP-B and phospholipids.肺表面活性物质蛋白SP-B和SP-C在气-水界面展开单分子层中的研究:I. 肺表面活性物质蛋白SP-B与磷脂的单分子层
Biophys J. 1994 Apr;66(4):1137-48. doi: 10.1016/S0006-3495(94)80895-1.
7
Pulmonary surfactant model systems catch the specific interaction of an amphiphilic peptide with anionic phospholipid.肺表面活性剂模型系统捕捉两亲性肽与阴离子磷脂之间的特定相互作用。
Biophys J. 2009 Feb 18;96(4):1415-29. doi: 10.1016/j.bpj.2008.11.022.
8
Alteration of surface properties of dipalmitoyl phosphatidylcholine by benzo[a]pyrene: a model of pulmonary effects of diesel exhaust inhalation.苯并[a]芘对二棕榈酰磷脂酰胆碱表面性质的改变:吸入柴油机废气对肺部影响的模型。
J Biomed Nanotechnol. 2012 Oct;8(5):818-25. doi: 10.1166/jbn.2012.1436.
9
Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: III. Proteins SP-B plus SP-C with phospholipids in spread monolayers.肺表面活性物质蛋白SP-B和SP-C在气-水界面的铺展单分子层中:III. 单分子层中含磷脂的蛋白SP-B加SP-C
Biophys J. 1994 Apr;66(4):1158-66. doi: 10.1016/S0006-3495(94)80897-5.
10
Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: II. Monolayers of pulmonary surfactant protein SP-C and phospholipids.肺表面活性物质蛋白SP-B和SP-C在气-水界面展开的单分子层中:II. 肺表面活性物质蛋白SP-C与磷脂的单分子层
Biophys J. 1994 Apr;66(4):1149-57. doi: 10.1016/S0006-3495(94)80896-3.

引用本文的文献

1
Impact of Natural-Based Viscosity Modifiers of Inhalation Drugs on the Dynamic Surface Properties of the Pulmonary Surfactant.吸入药物的天然粘度调节剂对肺表面活性剂动态表面性质的影响。
Materials (Basel). 2023 Feb 28;16(5):1975. doi: 10.3390/ma16051975.
2
Simulations reveal that antimicrobial BP100 induces local membrane thinning, slows lipid dynamics and favors water penetration.模拟结果表明,抗菌肽BP100可导致局部膜变薄,减缓脂质动力学并促进水渗透。
RSC Adv. 2022 Feb 4;12(8):4573-4588. doi: 10.1039/d1ra06267k. eCollection 2022 Feb 3.
3
Probing of Interactions of Magnetite Nanoparticles Coated with Native and Aminated Starch with a DPPC Model Membrane.
磁性纳米粒子与 DPPC 模型膜相互作用的研究:天然淀粉和氨化淀粉包覆的磁性纳米粒子。
Int J Mol Sci. 2021 May 31;22(11):5939. doi: 10.3390/ijms22115939.
4
Interactions of particulate matter and pulmonary surfactant: Implications for human health.颗粒物与肺表面活性剂的相互作用:对人类健康的影响。
Adv Colloid Interface Sci. 2020 Oct;284:102244. doi: 10.1016/j.cis.2020.102244. Epub 2020 Aug 19.